mBio (Apr 2023)

STLV-1 Commonly Targets Neurons in the Brain of Asymptomatic Non-Human Primates

  • Brenda Rocamonde,
  • Sandrine Alais,
  • Rodolphe Pelissier,
  • Valerie Moulin,
  • Brigitte Rimbaud,
  • Romain Lacoste,
  • Noemie Aurine,
  • Camille Baquerre,
  • Bertrand Pain,
  • Yuetsu Tanaka,
  • Cyrille Mathieu,
  • Hélène Dutartre

DOI
https://doi.org/10.1128/mbio.03526-22
Journal volume & issue
Vol. 14, no. 2

Abstract

Read online

ABSTRACT The human T-cell leukemia virus (HTLV)-1 is responsible for an aggressive neurodegenerative disease (HAM/TSP) and multiple neurological alterations. The capacity of HTLV-1 to infect central nervous system (CNS) resident cells, together with the neuroimmune-driven response, has not been well-established. Here, we combined the use of human induced pluripotent stem cells (hiPSC) and of naturally STLV-1-infected nonhuman primates (NHP) as models with which to investigate HTLV-1 neurotropism. Hence, neuronal cells obtained after hiPSC differentiation in neural polycultures were the main cell population infected by HTLV-1. Further, we report the infection of neurons with STLV-1 in spinal cord regions as well as in brain cortical and cerebellar sections of postmortem NHP. Additionally, reactive microglial cells were found in infected areas, suggesting an immune antiviral response. These results emphasize the need to develop new efficient models by which to understand HTLV-1 neuroinfection and suggest an alternative mechanism that leads to HAM/TSP.

Keywords